These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers. Young RS, Fortney K, Haley JC, Hood AF, Campagnari AA, Wang J, Bozue JA, Munson RS, Spinola SM. Infect Immun; 1999 Dec 23; 67(12):6335-40. PubMed ID: 10569746 [Abstract] [Full Text] [Related]
11. Attachment of Haemophilus ducreyi to human foreskin fibroblasts involves LOS and fibronectin. Alfa MJ, DeGagne P. Microb Pathog; 1997 Jan 23; 22(1):39-46. PubMed ID: 9032761 [Abstract] [Full Text] [Related]
12. Haemophilus ducreyi lipooligosaccharide mutant defective in expression of beta-1,4-glucosyltransferase is virulent in humans. Young RS, Filiatrault MJ, Fortney KR, Hood AF, Katz BP, Munson RS, Campagnari AA, Spinola SM. Infect Immun; 2001 Jun 23; 69(6):4180-4. PubMed ID: 11349097 [Abstract] [Full Text] [Related]
13. Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi strain 35000 and evidence for additional glycoforms. Melaugh W, Phillips NJ, Campagnari AA, Tullius MV, Gibson BW. Biochemistry; 1994 Nov 08; 33(44):13070-8. PubMed ID: 7947712 [Abstract] [Full Text] [Related]
14. Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi. Campagnari AA, Wild LM, Griffiths GE, Karalus RJ, Wirth MA, Spinola SM. Infect Immun; 1991 Aug 08; 59(8):2601-8. PubMed ID: 1855979 [Abstract] [Full Text] [Related]
15. Structurally defined epitopes of Haemophilus ducreyi lipooligosaccharides recognized by monoclonal antibodies. Ahmed HJ, Frisk A, Månsson JE, Schweda EK, Lagergård T. Infect Immun; 1997 Aug 08; 65(8):3151-8. PubMed ID: 9234768 [Abstract] [Full Text] [Related]
16. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid. Lagergård T. Microb Pathog; 1992 Sep 08; 13(3):203-17. PubMed ID: 1291843 [Abstract] [Full Text] [Related]
17. Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans. Spinola SM, Li W, Fortney KR, Janowicz DM, Zwickl B, Katz BP, Munson RS. Infect Immun; 2012 Feb 08; 80(2):679-87. PubMed ID: 22144477 [Abstract] [Full Text] [Related]
18. Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence. Bauer BA, Stevens MK, Hansen EJ. Infect Immun; 1998 Sep 08; 66(9):4290-8. PubMed ID: 9712780 [Abstract] [Full Text] [Related]
19. Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated. Mandrell RE, McLaughlin R, Aba Kwaik Y, Lesse A, Yamasaki R, Gibson B, Spinola SM, Apicella MA. Infect Immun; 1992 Apr 08; 60(4):1322-8. PubMed ID: 1372291 [Abstract] [Full Text] [Related]